메뉴 건너뛰기




Volumn 16, Issue 3, 2015, Pages 209-215

Association of IASLC/ATS/ERS histologic subtypes of lung adenocarcinoma with epidermal growth factor receptor mutations in 320 resected cases

Author keywords

Adenocarcinoma; Disease free survival; EGFR Lung cancer; Overall survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; PEMETREXED; PLATINUM; UFT;

EID: 84928632226     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2014.10.004     Document Type: Article
Times cited : (24)

References (34)
  • 1
    • 84901349294 scopus 로고    scopus 로고
    • A worldwide trend of increasing primary adenocarcinoma of the lung
    • H. Nakamura, and H. Saji A worldwide trend of increasing primary adenocarcinoma of the lung Surg Today 44 2014 1004 1012
    • (2014) Surg Today , vol.44 , pp. 1004-1012
    • Nakamura, H.1    Saji, H.2
  • 2
    • 84877975654 scopus 로고    scopus 로고
    • Diagnosis of lung adenocarcinoma in resected specimens: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification
    • W.D. Travis, E. Brambilla, and M. Noguchi Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification Arch Pathol Lab Med 137 2013 685 705
    • (2013) Arch Pathol Lab Med , vol.137 , pp. 685-705
    • Travis, W.D.1    Brambilla, E.2    Noguchi, M.3
  • 3
    • 2342471392 scopus 로고    scopus 로고
    • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
    • T. Lynch, D. Bell, and R. Sordella Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 2004 2129 2139
    • (2004) N Engl J Med , vol.350 , pp. 2129-2139
    • Lynch, T.1    Bell, D.2    Sordella, R.3
  • 4
    • 2342624080 scopus 로고    scopus 로고
    • EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy
    • J. Paez, P. Janne, and J. Lee EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500
    • (2004) Science , vol.304 , pp. 1497-1500
    • Paez, J.1    Janne, P.2    Lee, J.3
  • 5
    • 84859397680 scopus 로고    scopus 로고
    • Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis
    • Y. Zhang, Y. Sun, and Y. Pan Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis Clin Cancer Res 18 2012 1947 1953
    • (2012) Clin Cancer Res , vol.18 , pp. 1947-1953
    • Zhang, Y.1    Sun, Y.2    Pan, Y.3
  • 6
    • 84875235174 scopus 로고    scopus 로고
    • Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients - A single institution retrospective study of 292 lung adenocarcinoma
    • J. Gu, C. Lu, and J. Guo Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients - a single institution retrospective study of 292 lung adenocarcinoma J Surg Oncol 107 2013 474 480
    • (2013) J Surg Oncol , vol.107 , pp. 474-480
    • Gu, J.1    Lu, C.2    Guo, J.3
  • 7
    • 84879911109 scopus 로고    scopus 로고
    • Epidermal growth factor receptor mutation in lung adenocarcinomas: Relationship with CT characteristics and histologic subtypes
    • H.J. Lee, Y.T. Kim, and C.H. Kang Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes Radiology 268 2013 254 264
    • (2013) Radiology , vol.268 , pp. 254-264
    • Lee, H.J.1    Kim, Y.T.2    Kang, C.H.3
  • 8
    • 84871969337 scopus 로고    scopus 로고
    • Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: Analysis of 440 Japanese patients
    • A. Yoshizawa, S. Sumiyoshi, and M. Sonobe Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients J Thorac Oncol 8 2013 52 61
    • (2013) J Thorac Oncol , vol.8 , pp. 52-61
    • Yoshizawa, A.1    Sumiyoshi, S.2    Sonobe, M.3
  • 9
    • 84881662088 scopus 로고    scopus 로고
    • The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations
    • K. Tsuta, M. Kawago, and E. Inoue The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations Lung Cancer 81 2013 371 376
    • (2013) Lung Cancer , vol.81 , pp. 371-376
    • Tsuta, K.1    Kawago, M.2    Inoue, E.3
  • 10
    • 69949186250 scopus 로고    scopus 로고
    • Screening for epidermal growth factor receptor mutations in lung cancer
    • R. Rosell, T. Moran, and C. Queralt Screening for epidermal growth factor receptor mutations in lung cancer N Engl J Med 361 2009 958 967
    • (2009) N Engl J Med , vol.361 , pp. 958-967
    • Rosell, R.1    Moran, T.2    Queralt, C.3
  • 11
    • 84885191153 scopus 로고    scopus 로고
    • EGFR mutational status in a large series of Caucasian European NSCLC patients: Data from daily practice
    • S. Gahr, R. Stoehr, and E. Geissinger EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice Br J Cancer 109 2013 1821 1828
    • (2013) Br J Cancer , vol.109 , pp. 1821-1828
    • Gahr, S.1    Stoehr, R.2    Geissinger, E.3
  • 12
    • 34548457234 scopus 로고    scopus 로고
    • The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
    • P. Goldstraw, J. Crowley, and K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706 714
    • (2007) J Thorac Oncol , vol.2 , pp. 706-714
    • Goldstraw, P.1    Crowley, J.2    Chansky, K.3
  • 13
    • 80052264344 scopus 로고    scopus 로고
    • Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification
    • P.A. Russell, Z. Wainer, and G.M. Wright Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification J Thorac Oncol 6 2011 1496 1504
    • (2011) J Thorac Oncol , vol.6 , pp. 1496-1504
    • Russell, P.A.1    Wainer, Z.2    Wright, G.M.3
  • 14
    • 84885428606 scopus 로고    scopus 로고
    • Prognostic value of the IASLC/ATS/ERS classification in stage i lung adenocarcinoma patients - Based on a hospital study in China
    • Z. Song, H. Zhu, and Z. Guo Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients - based on a hospital study in China Eur J Surg Oncol 39 2013 1262 1268
    • (2013) Eur J Surg Oncol , vol.39 , pp. 1262-1268
    • Song, Z.1    Zhu, H.2    Guo, Z.3
  • 15
    • 23844465454 scopus 로고    scopus 로고
    • Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp
    • Y. Nagai, H. Miyazawa, and Huqun Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp Cancer Res 65 2005 7276 7282
    • (2005) Cancer Res , vol.65 , pp. 7276-7282
    • Nagai, Y.1    Miyazawa, H.2    Huqun3
  • 16
    • 38949177364 scopus 로고    scopus 로고
    • Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation
    • H. Miyazawa, T. Tanaka, and Y. Nagai Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation Cancer Sci 99 2008 595 600
    • (2008) Cancer Sci , vol.99 , pp. 595-600
    • Miyazawa, H.1    Tanaka, T.2    Nagai, Y.3
  • 17
    • 0001621471 scopus 로고
    • Note on an exact treatment of contingency, goodness of fit and other problems of significance
    • G. Freeman, and J. Halton Note on an exact treatment of contingency, goodness of fit and other problems of significance Biometrika 38 1951 141 149
    • (1951) Biometrika , vol.38 , pp. 141-149
    • Freeman, G.1    Halton, J.2
  • 18
    • 84888138347 scopus 로고    scopus 로고
    • Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage i lung adenocarcinoma
    • J.J. Hung, W.J. Jeng, and T.Y. Chou Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma Ann Surg 258 2013 1079 1086
    • (2013) Ann Surg , vol.258 , pp. 1079-1086
    • Hung, J.J.1    Jeng, W.J.2    Chou, T.Y.3
  • 19
    • 84907226113 scopus 로고    scopus 로고
    • The new histological classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: The experience of a French cohort
    • A. Mansuet-Lupo, A. Bobbio, and H. Blons The new histological classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort Chest 146 2014 633 643
    • (2014) Chest , vol.146 , pp. 633-643
    • Mansuet-Lupo, A.1    Bobbio, A.2    Blons, H.3
  • 20
    • 84860379332 scopus 로고    scopus 로고
    • The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival
    • A. Warth, T. Muley, and M. Meister The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival J Clin Oncol 30 2012 1438 1446
    • (2012) J Clin Oncol , vol.30 , pp. 1438-1446
    • Warth, A.1    Muley, T.2    Meister, M.3
  • 21
    • 79955571953 scopus 로고    scopus 로고
    • Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 stage i cases
    • A. Yoshizawa, N. Motoi, and G.J. Riely Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases Mod Pathol 24 2011 653 664
    • (2011) Mod Pathol , vol.24 , pp. 653-664
    • Yoshizawa, A.1    Motoi, N.2    Riely, G.J.3
  • 22
    • 84867404458 scopus 로고    scopus 로고
    • Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification
    • A. Warth, J. Cortis, and L. Fink Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification Virchows Arch 461 2012 185 193
    • (2012) Virchows Arch , vol.461 , pp. 185-193
    • Warth, A.1    Cortis, J.2    Fink, L.3
  • 23
    • 84896685538 scopus 로고    scopus 로고
    • Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma
    • D.H. Hwang, D.P. Szeto, and A.S. Perry Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma Arch Pathol Lab Med 138 2014 626 635
    • (2014) Arch Pathol Lab Med , vol.138 , pp. 626-635
    • Hwang, D.H.1    Szeto, D.P.2    Perry, A.S.3
  • 24
    • 84875405224 scopus 로고    scopus 로고
    • Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients
    • P.A. Russell, S.A. Barnett, and M. Walkiewicz Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients J Thorac Oncol 8 2013 461 468
    • (2013) J Thorac Oncol , vol.8 , pp. 461-468
    • Russell, P.A.1    Barnett, S.A.2    Walkiewicz, M.3
  • 25
    • 78751560428 scopus 로고    scopus 로고
    • Immunohistochemical detection of mutated epidermal growth factor receptors in pulmonary adenocarcinoma
    • H. Nakamura, A. Mochizuki, and T. Shinmyo Immunohistochemical detection of mutated epidermal growth factor receptors in pulmonary adenocarcinoma Anticancer Res 30 2010 5233 5237
    • (2010) Anticancer Res , vol.30 , pp. 5233-5237
    • Nakamura, H.1    Mochizuki, A.2    Shinmyo, T.3
  • 26
    • 84883769948 scopus 로고    scopus 로고
    • Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma
    • N. Tomonaga, Y. Nakamura, and H. Yamaguchi Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma Clin Lung Cancer 14 2013 521 526
    • (2013) Clin Lung Cancer , vol.14 , pp. 521-526
    • Tomonaga, N.1    Nakamura, Y.2    Yamaguchi, H.3
  • 27
    • 84883249629 scopus 로고    scopus 로고
    • The impact of EGFR mutation status on outcomes in patients with resected stage i non-small cell lung cancers
    • B. Izar, L. Sequist, and M. Lee The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers Ann Thorac Surg 96 2013 962 968
    • (2013) Ann Thorac Surg , vol.96 , pp. 962-968
    • Izar, B.1    Sequist, L.2    Lee, M.3
  • 28
    • 84903940270 scopus 로고    scopus 로고
    • Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension
    • M.W. Lin, C.T. Wu, and J.Y. Shih Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension J Surg Oncol 110 2014 99 106
    • (2014) J Surg Oncol , vol.110 , pp. 99-106
    • Lin, M.W.1    Wu, C.T.2    Shih, J.Y.3
  • 29
    • 84887550108 scopus 로고    scopus 로고
    • Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas
    • W.S. Liu, L.J. Zhao, and Q.S. Pang Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas Med Oncol 31 2014 771 776
    • (2014) Med Oncol , vol.31 , pp. 771-776
    • Liu, W.S.1    Zhao, L.J.2    Pang, Q.S.3
  • 30
    • 84928198468 scopus 로고    scopus 로고
    • Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection
    • Apr 22
    • Jeon JH, Kang CH, Kim HS, et al. Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection, Eur J Cardiothorac Surg Epub 2014 Apr 22.
    • (2014) Eur J Cardiothorac Surg Epub
    • Jeon, J.H.1    Ch, K.2    Kim, H.S.3
  • 31
    • 84883378283 scopus 로고    scopus 로고
    • Association of exon 19 and 21 EGFR mutation patterns with treatment outcome after first-line tyrosine kinase inhibitor in metastatic non-small-cell lung cancer
    • V.H. Lee, V.P. Tin, and T.S. Choy Association of exon 19 and 21 EGFR mutation patterns with treatment outcome after first-line tyrosine kinase inhibitor in metastatic non-small-cell lung cancer J Thorac Oncol 8 2013 1148 1155
    • (2013) J Thorac Oncol , vol.8 , pp. 1148-1155
    • Lee, V.H.1    Tin, V.P.2    Choy, T.S.3
  • 32
    • 33746034167 scopus 로고    scopus 로고
    • Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib
    • D.M. Jackman, B.Y. Yeap, and L.V. Sequist Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib Clin Cancer Res 12 2006 3908 3914
    • (2006) Clin Cancer Res , vol.12 , pp. 3908-3914
    • Jackman, D.M.1    Yeap, B.Y.2    Sequist, L.V.3
  • 33
    • 79954450183 scopus 로고    scopus 로고
    • The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients
    • J.M. Sun, Y.W. Won, and S.T. Kim The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients J Cancer Res Clin Oncol 137 2011 687 694
    • (2011) J Cancer Res Clin Oncol , vol.137 , pp. 687-694
    • Sun, J.M.1    Won, Y.W.2    Kim, S.T.3
  • 34
    • 80054964152 scopus 로고    scopus 로고
    • Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations
    • Y.W. Won, J.Y. Han, and G.K. Lee Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations J Clin Pathol 64 2011 947 952
    • (2011) J Clin Pathol , vol.64 , pp. 947-952
    • Won, Y.W.1    Han, J.Y.2    Lee, G.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.